Cassia fistula (Fabaceae) Amaltas, Golden Shower Tree

Das K
4 days ago
13 min read

Updated: 3 days ago

Cassia fistula, the golden shower tree, is one of the most revered medicinal plants in traditional medicine systems across South and Southeast Asia. Known as Aragvadha or Amaltas, it is most notably used as a gentle yet effective laxative, a potent anti-inflammatory agent, and a comprehensive hepatoprotective herb. The fruit pulp is a classic Ayurvedic remedy for constipation and gastrointestinal disorders, while modern research has validated its profound anti-arthritic, antioxidant, antidiabetic, and ulcer-protective properties. Cutting-edge 2025 and 2026 studies have elucidated its mechanisms in rheumatoid arthritis via NF-κB pathway inhibition, its therapeutic potential in ulcerative colitis through caspase-3 and COX-2 modulation, and the development of gold nanoparticles from leaf extracts for anti-obesity and anti-ulcer applications, positioning Cassia fistula at the forefront of evidence-based phytomedicine.

1. Taxonomic Insights

Species: Cassia fistula L.

Family: Fabaceae (Caesalpinioideae subfamily)

The Fabaceae family, also known as Leguminosae, is one of the largest families of flowering plants, comprising approximately 630 genera and 18,000 species. It is characterized by compound leaves, legume fruits, and often the presence of nitrogen-fixing nodules. The Caesalpinioideae subfamily, to which Cassia belongs, is distinguished by flowers with five petals that are often showy and asymmetrical.

Taxonomic Note: The name Cassia is derived from the Greek word "kassia," meaning fragrant, while the specific epithet fistula comes from the Latin for "tube" or "pipe," referring to the cylindrical shape of the fruit pods. The tree was first described by Carl Linnaeus in 1753.

Related Herbs from the Same Family:

· Cassia angustifolia (Senna): A closely related species renowned for its potent laxative properties, containing high levels of sennosides. It is more potent than C. fistula and is used for severe constipation.

· Cassia tora (Foetid Cassia): Used traditionally for skin diseases, hypertension, and as an anthelmintic.

· Tamarindus indica (Tamarind): A tropical tree with edible fruit pulp used as a gentle laxative and for its antioxidant and cardioprotective properties.

· Saraca asoca (Ashoka): A sacred tree used extensively in Ayurveda for female reproductive health and as a uterine tonic.

---

2. Common Names

---

3. Medicinal Uses

Primary Actions: Laxative, Anti-inflammatory, Anti-arthritic, Antioxidant, Hepatoprotective, Antimicrobial, Antidiabetic, Anti-ulcer.

Secondary Actions: Anticancer, Antipyretic, Analgesic, Antifungal, Cardioprotective, Immunomodulatory, Wound healing, Antidysenteric.

Medicinal Parts:

Every part of the tree—the fruit pulp, bark, leaves, flowers, seeds, and roots—is used medicinally, each with specific therapeutic indications.

· Fruit Pulp (Amaltas Pulp): The most widely used part, prized as a gentle laxative for constipation in all age groups, including children and the elderly. It is also used for fever, chest pain, cardiac disorders, and as a cholagogue.

· Stem Bark: Used for its anti-inflammatory, anti-ulcer, and antimicrobial properties. Applied topically for skin diseases and taken internally for leprosy, tuberculosis, and syphilis.

· Leaves: Employed for their anti-inflammatory, anti-arthritic, and wound healing properties. Leaf extracts have shown potent NF-κB inhibition in recent studies.

· Flowers: Used for their antioxidant, antibacterial, and hepatoprotective activities.

· Seeds: Utilized for their antimicrobial and anti-inflammatory effects.

· Roots: Considered astringent, febrifuge, and tonic, used to treat fevers, skin conditions, and as a strong purgative.

---

4. Phytochemicals Specific to the Plant and Their Action

Anthraquinones (The Signature Laxative and Anti-inflammatory Agents)

· Sennosides A and B (Sennoside B): The primary anthraquinone glycosides responsible for the laxative effect. A 2025-2026 study confirmed sennoside B as a potent NF-κB inhibitor and anti-inflammatory agent.

· Rhein and Chrysophanol: These anthraquinones exhibit significant Anti-inflammatory, Anti-arthritic, and Antioxidant activities. A 2025 study validated their efficacy in reducing IL-1β, TNF-α, and reactive oxygen species.

· Emodin and Aloe-emodin: Less abundant but contribute Anticancer, Antimicrobial, and Hepatoprotective effects.

Flavonoids (The Antioxidant, Anti-inflammatory, and Cardioprotective Matrix)

· Kaempferol, Quercetin, Apigenin, Luteolin: These flavonoids are responsible for potent Antioxidant activity, free radical scavenging, and inhibition of lipid peroxidation. They contribute significantly to the plant's anti-inflammatory and cardioprotective profiles.

Tannins and Polyphenols (The Astringent and Wound Healing Arm)

· Condensed Tannins: Provide Astringent, Wound healing, and Antimicrobial properties.

· Procyanidin B2 and Catechin: A 2024 study identified procyanidin B2 as having potent interactions with COX-2 and caspase-3 proteins, explaining its Anti-ulcerative and Anti-inflammatory mechanisms.

Triterpenoids and Sterols

· Lupeol, β-sitosterol: These compounds contribute Anti-inflammatory, Hepatoprotective, and Anticancer activities. Lupeol has demonstrated efficacy in reducing edema and inflammation in animal models.

Other Bioactive Compounds

· Fistulic Acid: A unique compound isolated from the plant with documented pharmacological activities.

· Leucocyanidin and Leucopelargonidin: Proanthocyanidins with antioxidant properties.

---

5. Traditional and Ethnobotanical Uses Covering the Medicinal Uses

Vibandha (Constipation) & Kostha Shuddhi (Bowel Cleansing)

Formulation: Fruit pulp powder (Amaltas Churna) or pulp decoction.

Preparation & Use: The sweet, sticky pulp of the ripe fruit pod is a classic, gentle laxative. 10-20 grams of the pulp is taken internally. It is considered safe for children, the elderly, and during pregnancy, making it unique among potent laxatives.

Reasoning: The anthraquinone glycosides (sennosides) are metabolized by gut bacteria into active rhein-anthrone, which stimulates colonic peristalsis and inhibits water and electrolyte absorption, producing a soft, formed stool without the griping associated with other purgatives.

Ama Vata (Rheumatoid Arthritis) & Sandhivata (Osteoarthritis)

Formulation: Leaf extracts, fruit pulp decoction, or bark preparations.

Preparation & Use: The plant is widely used in Ayurveda for joint disorders, often as part of multi-ingredient formulations.

Reasoning: Recent 2025-2026 research provides robust validation. Ethanolic leaf extract significantly inhibits NF-κB signaling, reducing pro-inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-17a) and restoring redox imbalance. This leads to reduced cartilage degradation, osteoclastogenesis (via suppressed RANKL and MMPs), and improvement in joint microarchitecture. Sennoside B was identified as a key contributor to this effect.

Kamala (Jaundice) & Yakrit Vikara (Liver Disorders)

Formulation: Fruit pulp decoction, leaf infusion, or flower preparations.

Preparation & Use: The entire plant is considered a potent hepatoprotective and cholagogue (bile flow stimulant). The fruit pulp is used to treat jaundice and other liver complaints.

Reasoning: The antioxidant flavonoids (kaempferol, quercetin) scavenge free radicals that damage hepatocytes. Rhein and emodin have also demonstrated hepatoprotective activity in preclinical studies.

Pravahika (Ulcerative Colitis) & Atisara (Dysentery)

Formulation: Bark decoction, leaf extract, or pulp preparation.

Preparation & Use: Recent formulations have utilized Cassia fistula for inflammatory bowel conditions.

Reasoning: A 2024 study demonstrated that Cassia fistula leaf extracts ameliorate acetic acid-induced ulcerative colitis in rats. The ethyl acetate fraction, rich in phenolics and flavonoids (TPC of 12.36 mg GAE/100mg), showed significant in vitro antioxidant activity. The effect was dose-dependent and involved inhibition of COX-2 and caspase-3. Molecular docking identified that emodin binds strongly to COX-2, while isorhamnetin and procyanidin B2 show high affinity for caspase-3, explaining the anti-inflammatory and anti-apoptotic mechanisms.

Prameha (Diabetes) & Medoroga (Metabolic Disorders)

Formulation: Fruit pulp decoction, leaf extracts.

Preparation & Use: The plant is traditionally used to manage diabetes and metabolic imbalances.

Reasoning: Recent research confirms antidiabetic potential through α-glucosidase inhibition, reducing postprandial glucose absorption. Cassia fistula-mediated gold nanoparticles (CFL-AuNPs) demonstrated moderate α-glucosidase inhibition (42.93%). The flavonoids kaempferol and quercetin also contribute to improved insulin sensitivity.

Kushtha (Skin Diseases) & Vrana (Wounds)

Formulation: Bark powder or leaf paste for topical application; leaf juice.

Preparation & Use: The leaves and bark are applied as poultices to treat skin eruptions, ulcers, inflammation, and insect bites. The leaf juice is used for parasitic skin conditions.

Reasoning: The antimicrobial, anti-inflammatory, and astringent properties of tannins, flavonoids, and anthraquinones reduce infection, swelling, and promote wound contraction.

Jwara (Fever)

Formulation: Fruit pulp decoction or bark decoction.

Preparation & Use: Traditional texts describe its use as a febrifuge for treating intermittent and remittent fevers, including malaria.

Reasoning: The antipyretic and antimalarial properties are attributed to its anthraquinones and other bioactive compounds.

---

6. Healing Recipes, Decoctions, and Preparations

Gentle Laxative Fruit Pulp (Amaltas Churna)

Purpose: For chronic and acute constipation, bowel cleansing.

Preparation & Use:

1. Remove the seeds from dried Cassia fistula fruit pods.

2. Collect the sweet, sticky pulp and dry it slightly. Grind to a coarse powder or break into small pieces.

3. Take 10-15 grams of the pulp (approximately 1 tablespoon) at bedtime with warm water or milk.

4. Stools will typically be passed in 6-12 hours without griping. This is safe for occasional use in children and the elderly.

Anti-inflammatory Leaf Decoction for Arthritis

Purpose: Supportive therapy for rheumatoid and osteoarthritis (under professional guidance).

Preparation & Use:

1. Take 10-15 fresh Cassia fistula leaves, washed thoroughly.

2. Simmer in 500 ml of water for 15-20 minutes until reduced to 250 ml.

3. Strain and divide into two doses. Drink morning and evening.

4. This may be used alongside conventional treatment. Discontinue if any adverse effects occur.

Hepatoprotective Fruit Pulp Decoction (for Jaundice)

Preparation & Use:

1. Take 10 grams of fresh or dried fruit pulp.

2. Simmer in 500 ml of water for 10-15 minutes.

3. Strain and drink 100-150 ml twice daily for 1-2 weeks as supportive therapy for liver disorders.

Antibacterial Flower Infusion

Preparation & Use:

1. Steep 5-10 fresh or dried yellow flowers in 1 cup of boiling water for 10 minutes.

2. Strain and drink as a gentle antioxidant and antibacterial beverage.

Topical Anti-inflammatory Leaf Poultice

Purpose: For boils, skin inflammation, ulcers, and insect bites.

Preparation & Use:

1. Crush a handful of fresh Cassia fistula leaves into a smooth paste.

2. Apply directly to the affected area and cover with a clean cloth.

3. Change twice daily.

---

7. In-Depth Phytochemical Profile and Clinical Significance of Cassia fistula (Amaltas)

Introduction

Cassia fistula, the golden shower tree, is a botanical treasure whose vibrant yellow blossoms belie a profound medicinal depth. Revered as "Aragvadha" or "disease killer" in Sanskrit, it has been a cornerstone of Ayurvedic medicine for millennia, primarily as a gentle yet effective laxative and a comprehensive hepatobiliary tonic. However, recent scientific inquiry, particularly from 2024 to 2026, has dramatically expanded our understanding of this plant. No longer merely a purgative, Cassia fistula is now recognized as a sophisticated immunomodulatory and anti-inflammatory agent with validated mechanisms at the molecular level. Landmark studies have elucidated its ability to inhibit the NF-κB signaling pathway in rheumatoid arthritis, modulate COX-2 and caspase-3 in ulcerative colitis, and serve as a green source for bioactive gold nanoparticles with anti-obesity and anti-ulcer potential. This convergence of traditional wisdom with cutting-edge pharmacology positions Cassia fistula at the vanguard of evidence-based phytomedicine.

1. Anthraquinones: The Signature Bioactive Agents for Gut Motility and Inflammation

Key Compounds: Sennosides A & B, Rhein, Chrysophanol, Emodin.

Actions and Clinical Relevance:

· Laxative (Traditional and Clinically Validated): The sennosides are the classic laxative compounds. They are prodrugs that are not absorbed in the small intestine but are metabolized by colonic bacteria into rhein-anthrone, the active metabolite. Rhein-anthrone stimulates peristalsis by increasing prostaglandin and nitric oxide production, while also inhibiting water and electrolyte absorption. This results in a soft, formed stool typically passed 6-12 hours after ingestion, with minimal cramping, making it exceptionally safe for all ages.

· Anti-arthritic and NF-κB Inhibition (2025-2026 Breakthrough): A pivotal 2025-2026 study published in Inflammopharmacology investigated the anti-arthritic potential of Cassia fistula leaf extracts and sennoside B. The research demonstrated that the ethanolic extract significantly inhibited NF-κB signaling at both transcriptional and translational levels. This inhibition led to a marked reduction in pro-inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-17a) and a restoration of redox balance (reduced NO and MDA, augmented catalase and reduced glutathione). The suppressed NF-κB activity further downregulated tissue remodeling markers (MMP-2, MMP-9, MMP-13) and osteoclastogenesis (RANKL), resulting in the protection of joint microstructure. Sennoside B itself showed strong anti-inflammatory and NF-κB inhibition against LPS-stimulated peritoneal macrophages. This study provides the first high-level mechanistic validation of the plant's traditional use in rheumatism.

· Anti-arthritic via Fruit Pulp (2025 Study): A concurrent 2025 study confirmed that Cassia fistula fruit pulp extracts also mitigate collagen-induced arthritis. Chrysophanol and rhein, at 10 µM, demonstrated significant anti-inflammatory potential by inhibiting IL-1β, IL-6, and TNF-α. The ethanolic extract significantly reduced paw swelling and disease score, and histopathology revealed improved joint space and reduced cellular infiltration.

2. Flavonoids and Phenolics: The Antioxidant and Ulcer-Protective Matrix

Key Compounds: Kaempferol, Quercetin, Procyanidin B2, Catechin, Isorhamnetin.

Quantitative Profile: The ethyl acetate fraction of leaves showed total phenolic content of 12.36 ± 1.46 mg GAE/100 mg and total flavonoid content of 5.12 ± 0.64 mg QE/100 mg.

Actions and Clinical Relevance:

· Anti-ulcerative Colitis (2024 Breakthrough): A 2024 study published in the Arabian Journal of Chemistry investigated Cassia fistula leaf extracts in a rat model of ulcerative colitis (UC). The ethyl acetate fraction showed impressive in vitro antioxidant activity (DPPH IC50 of 12.7 µg/mL). LC-ESI-MS/MS identified 55 compounds, predominantly phenolics. The crude extract dose-dependently ameliorated UC, improving hematological parameters, liver biomarkers, oxidative stress, and histopathology. Molecular docking revealed that emodin had the highest binding affinity for COX-2, isorhamnetin showed the best binding to caspase-3, and procyanidin B2 exhibited potent interactions with both targets. This provides a mechanistic basis for the plant's anti-inflammatory and anti-apoptotic effects in UC.

· Antioxidant (Consistently Validated): The flavonoid-rich matrix provides comprehensive free radical scavenging. Kaempferol, quercetin, and apigenin donate hydrogen atoms to neutralize peroxyl, hydroxyl, and superoxide radicals, protecting cellular lipids, proteins, and DNA from oxidative damage. This foundational activity underpins the hepatoprotective, cardioprotective, and anti-aging claims.

3. Nanotechnology Applications: Green Synthesis and Multitasking Nanoparticles (2026 Breakthrough)

Key Development: A 2026 study in Discover Chemistry reported the green synthesis of gold nanoparticles (CFL-AuNPs) using aqueous Cassia fistula leaf extract.

Characterization: The nanoparticles formed a stable wine-red colloid with a maximum absorption peak at 560 nm. They were nearly spherical, measured 10-50 nm in size, and had a stable zeta potential (39.3 mV in a related 2025 flower study), indicating good physical stability and resistance to aggregation.

Actions and Clinical Relevance:

· Anti-obesity (Potent): CFL-AuNPs exhibited strong pancreatic lipase inhibition (88.93%), closely matching the pharmaceutical drug Orlistat (89.46%). By inhibiting lipase, these nanoparticles prevent the absorption of dietary fats and triglycerides, potentially reducing caloric intake and managing obesity.

· Anti-ulcer (Highly Potent): CFL-AuNPs showed exceptionally high H⁺/K⁺-ATPase inhibition (84.60%), outperforming the standard drug acetaminophen (73.89%). H⁺/K⁺-ATPase is the gastric proton pump responsible for acid secretion; its inhibition is the mechanism of proton pump inhibitors (PPIs) used for peptic ulcers. This is among the first reports of plant-mediated gold nanoparticles demonstrating this activity.

· Antifungal: CFL-AuNPs inhibited foodborne Aspergillus flavus (50.70%), A. fumigatus (47.73%), A. niger (44.29%), and Fusarium solani (47.65%), suggesting potential as a nano-preservative.

· Antidiabetic (Moderate): They exhibited moderate α-glucosidase inhibition (42.93%), indicating potential for managing postprandial blood glucose.

4. Triterpenoids, Tannins, and Other Bioactive Compounds

Key Compounds: Lupeol, β-sitosterol, Procyanidin B2, Catechin.

Actions and Clinical Relevance:

· Anti-inflammatory (Lupeol and β-sitosterol): Lupeol inhibits paw edema in animal models, while β-sitosterol reduces levels of inflammatory prostaglandins. These compounds complement the NF-κB inhibition of the anthraquinones.

· Anti-ulcer (Procyanidin B2): The high binding affinity of procyanidin B2 to COX-2 and caspase-3 provides a molecular rationale for its gastroprotective effects, reducing both inflammation and apoptosis in the gastric mucosa.

An Integrated View of Healing in Cassia fistula

· For Rheumatoid Arthritis and Autoimmune Joint Disorders: Cassia fistula offers a sophisticated, multi-level approach to managing RA. First, central pathway inhibition: The ethanolic leaf extract and sennoside B directly inhibit NF-κB, the master transcriptional regulator of inflammation. Second, cytokine suppression: This leads to reduced production of the key inflammatory drivers IL-1β, TNF-α, IL-6, and IL-17a. Third, oxidative stress restoration: The extracts rebalance redox markers (NO, MDA, GSH, catalase). Fourth, joint protection: Reduced NF-κB activity suppresses MMPs and RANKL, preventing cartilage degradation and osteoclastogenesis. This combined action was validated by improved joint histopathology and reduced paw swelling, making C. fistula a promising complementary therapy for RA.

· For Inflammatory Bowel Disease (Ulcerative Colitis): The 2024 study reveals a similar multi-target strategy for UC. The flavonoid and phenolic-rich extracts inhibit COX-2 (via emodin and procyanidin B2) and caspase-3 (via isorhamnetin), reducing both inflammation and apoptosis in the colonic mucosa. The local astringent action of tannins provides symptomatic relief, while the systemic antioxidant activity reduces oxidative damage. This integrated approach addresses both the acute inflammation and the long-term tissue damage characteristic of UC.

· For Metabolic Health (Obesity and Diabetes): The 2026 nanotechnology breakthrough introduces a novel dimension. Cassia fistula-derived gold nanoparticles simultaneously inhibit pancreatic lipase (anti-obesity) and α-glucosidase (anti-diabetic). This positions C. fistula as a potential source of nutraceuticals for metabolic syndrome, addressing two major components of the condition with a single, green-synthesized agent. The nanoparticles' stability and multi-target activity suggest significant potential for pharmaceutical development.

· For Gastrointestinal Health (Constipation and Other Disorders): The plant's traditional use as a laxative remains its most well-known application. The sennoside-based mechanism is gentle, predictable, and suitable for all populations. However, recent research suggests its benefits extend beyond simple purgation to include anti-ulcer (via H⁺/K⁺-ATPase inhibition) and anti-UC effects, transforming our understanding of its gastrointestinal pharmacology.

Toxicological Profile and Safety Considerations

Cassia fistula has a long history of traditional use and is generally considered safe in therapeutic doses. A 2006 acute toxicity study of the bark found no signs of toxicity up to 2000 mg/kg.

However, specific considerations apply:

Sennosides: At high doses or with prolonged use, sennosides can cause abdominal cramps, electrolyte imbalance, melanosis coli, and laxative dependence. It is not recommended for long-term daily use. The therapeutic dose (10-15 g of pulp) is well-tolerated.

Pregnancy and Lactation: While the fruit pulp is traditionally considered safe during pregnancy, modern authorities recommend caution with all anthraquinone laxatives, especially in the first trimester. Therapeutic use should be under professional guidance.

Drug Interactions: Due to its effects on gut motility and absorption, simultaneous use with other oral medications may reduce their absorption. It should be taken at least 2 hours apart from other drugs. Its anti-inflammatory and potential anticoagulant effects suggest caution when combining with blood thinners or NSAIDs.

Conclusion: Cassia fistula, the golden shower tree, has undergone a remarkable transformation in scientific understanding. Once considered primarily a gentle laxative, it is now recognized as a sophisticated immunomodulator with validated mechanisms in rheumatoid arthritis (NF-κB inhibition), ulcerative colitis (COX-2/caspase-3 modulation), and metabolic syndrome (via green-synthesized nanoparticles). The 2025 and 2026 studies have provided unprecedented molecular validation for its traditional uses, while opening new avenues in nanotechnology. Its favorable safety profile, combined with its multi-target therapeutic potential, positions C. fistula as a prime candidate for the development of evidence-based phytomedicines. As research continues to unravel its complexities, this "disease killer" of Ayurveda is poised to contribute significantly to modern pharmacotherapy.

---

Disclaimer:

Cassia fistula is generally recognized as safe based on extensive traditional use and recent toxicological studies. However, the fruit pulp should not be used as a daily laxative for extended periods due to the risk of dependence and electrolyte imbalance. The seeds and unripe pods contain higher concentrations of anthraquinones and may cause severe purging; only ripe fruit pulp should be used internally. Pregnant women, especially in the first trimester, should use only under professional guidance. Individuals with intestinal obstruction, acute abdominal pain, or inflammatory bowel disease complicated by obstruction should not use this as a laxative. This information is for educational purposes only and is not a substitute for professional medical advice.

---

8. Reference Books, Books for In-depth Study:

· Indian Medicinal Plants: An Illustrated Dictionary by C.P. Khare

· The Ayurvedic Pharmacopoeia of India (relevant volumes)

· Wealth of India: Raw Materials (CSIR publication)

· Quality Standards of Indian Medicinal Plants (Indian Council of Medical Research)

· Medicinal Plants of India by S.K. Jain

· Indian Materia Medica by Dr. K.M. Nadkarni

---

9. Further Study: Plants That Might Interest You Due to Similar Medicinal Properties

1. Cassia angustifolia (Senna)

· Species: Cassia angustifolia | Family: Fabaceae

· Similarities: The closest relative in terms of medicinal action, sharing the anthraquinone-rich profile. While both are laxatives, Senna is much more potent and is used for severe constipation, whereas C. fistula is preferred as a gentle laxative for children and the elderly.

2. Aloe barbadensis (Aloe Vera)

· Species: Aloe barbadensis | Family: Asphodelaceae

· Similarities: Both contain anthraquinone compounds (aloin in Aloe, sennosides in Cassia) that act as potent laxatives. Both plants also have extensive topical applications for wound healing and skin conditions. Aloe is more renowned for its soothing gel, while Cassia is more recognized for its systemic anti-inflammatory effects.

3. Terminalia chebula (Haritaki)

· Species: Terminalia chebula | Family: Combretaceae

· Similarities: Haritaki is known as the "King of Medicines" in Ayurveda and shares with Cassia fistula a reputation as a gentle laxative, a Rasayana (rejuvenative), and a hepatoprotective agent. Both are key ingredients in many digestive formulations.

4. Rheum rhabarbarum (Rhubarb)

· Species: Rheum rhabarbarum | Family: Polygonaceae

· Similarities: Rhubarb root contains anthraquinones (rhein, emodin) identical to those found in Cassia fistula and is used as a laxative. Both plants have been studied for their anticancer and anti-inflammatory properties, though Cassia is more extensively used in traditional medicine systems.

---

-x-x-x-End-x-x-x-

PREHEALING

Cassia fistula (Fabaceae) Amaltas, Golden Shower Tree

Recent Posts

Comments